Epidemiological, Immunological, Pathological and Pharmacogenetic Study of Cancers Occuring After Solid Organs Transplants
18 Years
N/A
Both
Cancer, Organ Transplantation
Trial Information
Epidemiological, Immunological, Pathological and Pharmacogenetic Study of Cancers Occuring After Solid Organs Transplants
This is an observational and comparative study (2 control patients are recruited for each 1
case patient).
A case patient is a patient who has developed a cancer after his/her transplant.
A control patient is a patient who has not developed a cancer after his/her transplant.
These 2 groups will be matched according to specific inclusion criteria.
Inclusion Criteria:
- Man or woman after 18 years old
- Transplanted with a solid organ (heart, kidney, lung,liver)
- Informed Consent Form signed
- For the patients-case: Patients who developed a post-transplant cancer
- For the patients-control: Patients who didn't develop a post-transplant cancer
Exclusion Criteria:
- Cancer as transplant indication ( except liver )
- HIV positive
Type of Study:
Observational
Study Design:
Observational Model: Case Control, Time Perspective: Prospective
Outcome Measure:
Incidence of cancer among transplanted patients.
Outcome Time Frame:
At the day of blood collection
Safety Issue:
Yes
Principal Investigator
Michel MARTY, MD
Investigator Role:
Principal Investigator
Investigator Affiliation:
Assistance Publique - Hôpitaux de Paris
Authority:
France: Ministry of Health
Study ID:
DRCD CANC 0701
NCT ID:
NCT00948883
Start Date:
October 2008
Completion Date:
July 2011
Related Keywords:
- Cancer
- Organ Transplantation
- organ transplant
- cancer
- biobank
- immunosuppressive drugs
- lymphoma
Name | Location |
|---|
